glp-1 digital health startups What's next for innovation: A primer on the race reshaping pharma and chronic disease care Q1 2025 market overview: Ready,

Soon after developing GLP-1s, researchers uncovered a second therapeutic effect that could benefit an even larger patient population: sustainable, clinically meaningful weight loss

Studies examining context-dependent effects found that Melanotan II administration in social contexts, but not non-social contexts, increased oxytocin-dependent neuronal activation in the nucleus accumbens

Steed H, Walsh S, Reynolds N

Traditional immunosuppressants work like a volume knob turned all the way down

In contrast to earlier findings in FM and other disorders, ALCAR did not

Potential advantages for anti-aging, bone density, and recuperation are also suggested by preliminary research